{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:21:56Z","timestamp":1740126116051,"version":"3.37.3"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1111\/bjd.17027","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T09:37:58Z","timestamp":1531993078000},"page":"1015-1015","source":"Crossref","is-referenced-by-count":0,"title":["Mepacrine-induced interstitial lung disease in discoid lupus erythematosus?"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-7190","authenticated-orcid":false,"given":"R.L.V.","family":"Waas","sequence":"first","affiliation":[{"name":"Department of Dermatology; Royal Victoria Infirmary; Newcastle upon Tyne U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Meggitt","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Royal Victoria Infirmary; Newcastle upon Tyne U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"10.1111\/bjd.17027-BIB0001|bjd17027-cit-0001","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus","volume":"166","author":"Chong","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.17027-BIB0002|bjd17027-cit-0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/thorax.55.2.159","article-title":"Pleuropulmonary manifestations of systemic lupus erythematosus","volume":"55","author":"Keane","year":"2000","journal-title":"Thorax"},{"key":"10.1111\/bjd.17027-BIB0003|bjd17027-cit-0003","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/thx.48.8.790","article-title":"Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin","volume":"48","author":"Koldsland","year":"1993","journal-title":"Thorax"},{"key":"10.1111\/bjd.17027-BIB0004|bjd17027-cit-0004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/pds.1399","article-title":"Guidelines for submitting adverse event reports for publication","volume":"16","author":"Kelly","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.17027","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.17027\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:42:50Z","timestamp":1676382170000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/4\/1015\/6753826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.17027","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2018,8,23]]}}}